Kanazawa K, Suematsu M, Ishida T, Hirata K, Kawashima S, Akita H, Yokoyama M
First Department of Internal Medicine, School of Medicine, Kobe University, Japan.
Clin Cardiol. 1997 Feb;20(2):146-52. doi: 10.1002/clc.4960200212.
Intrinsic vasoactive substances, such as serotonin and acetylcholine, are known to provoke coronary artery spasm in patients with vasospastic angina. It remains unclear, however, whether these different agents, which activate different receptors, produce spasms at the same sites in these patients. The present study was designed to clarify the disparity of receptor agonist-induced coronary artery spasms in the same patients.
We conducted sequential provocative tests of coronary artery spasm by acetylcholine, serotonin, and ergonovine in 20 patients with rest angina examined with quantitative coronary angiography.
Coronary artery spasms were provoked in all patients at 27 spastic sites. In 13 patients, ergonovine provoked spasms and in 10 of 13 patients who were diagnosed with variant angina, both acetylcholine and serotonin provoked spasms at the same sites where ergonovine also did. In 4 of 13 patients, spasms were provoked by serotonin but not by acetylcholine. In the remaining seven patients, whose spasms were induced by ergonovine, spasms were produced by acetylcholine but not by serotonin. On coronary angiography, the spastic sites for both acetylcholine and serotonin, and those for serotonin alone, were located in the proximal segments of coronary arteries, whereas the spastic sites for acetylcholine alone were located in the distal segments.
This study documented the disparity between serotonin- and acetylcholine-induced spasms. Provocative tests using agents that activate different receptors may produce coronary artery spasms at the same and/or different sites, and this disparity may reflect the clinical heterogeneity of vasospastic ischemic syndrome.
已知血清素和乙酰胆碱等内源性血管活性物质可诱发血管痉挛性心绞痛患者的冠状动脉痉挛。然而,这些激活不同受体的不同药物是否会在这些患者的相同部位引发痉挛仍不清楚。本研究旨在阐明同一患者中受体激动剂诱发的冠状动脉痉挛的差异。
我们对20例静息性心绞痛患者进行了乙酰胆碱、血清素和麦角新碱诱发冠状动脉痉挛的序贯激发试验,并采用定量冠状动脉造影进行检查。
所有患者在27个痉挛部位均诱发了冠状动脉痉挛。在13例患者中,麦角新碱诱发了痉挛,在13例被诊断为变异型心绞痛的患者中,有10例患者的乙酰胆碱和血清素在麦角新碱诱发痉挛的相同部位也诱发了痉挛。在13例患者中有4例,血清素诱发了痉挛,但乙酰胆碱未诱发。在其余7例由麦角新碱诱发痉挛的患者中,乙酰胆碱诱发了痉挛,但血清素未诱发。在冠状动脉造影中,乙酰胆碱和血清素共同的痉挛部位以及仅由血清素诱发痉挛的部位位于冠状动脉近端节段,而仅由乙酰胆碱诱发痉挛的部位位于远端节段。
本研究记录了血清素和乙酰胆碱诱发痉挛之间的差异。使用激活不同受体的药物进行激发试验可能会在相同和/或不同部位产生冠状动脉痉挛,这种差异可能反映了血管痉挛性缺血综合征的临床异质性。